Incorporating Biomarkers of Exposure and Genetic Susceptibility into Smoking Cessation Treatment: Effects on Smoking-Related Cognitions, Emotions, and Behavior Change

Health Psychology

Volumn 16, Issue 1, 1997, Pages 87-99

  Lerman, Caryn ^d   Gold, Karen ^e   Audrain, Janet ^e   Lin, Ting Hsiang ^e   Orleans, C Tracy ^b   Boyd, Neal R ^a   Wilfond, Ben ^e   Louben, Greg ^e   Caporaso, Neil ^c  

^a FOX CHASE CANCER CENTER   (United States)

^b ROBERT WOOD JOHNSON FOUNDATION   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e NONE

Author keywords

Counseling; Genetics; Risk notification; Smoking

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATTITUDE TO HEALTH; BREATH ANALYSIS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; GENETIC SCREENING; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; LUNG TUMOR; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK; SMOKING CESSATION; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PROGRAM EVALUATION; SMOKING CESSATION; TREATMENT OUTCOME; TRUTH DISCLOSURE;

EID: 0030635988     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.16.1.87     Document Type: Article

References (50)

1. American Cancer Society. (1996). Cancer facts and figures, 1996. Atlanta, GA: Author.
2. American Society of Human Genetics. (1994). Statement of The American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. American Journal of Human Genetics, 55, i-iv.
3. Amos, C. I., Caporaso, N. E., & Weston, A. (1992). Host factors in lung cancer risk: A review of interdisciplinary studies. Cancer Epidemiology, Biomarkers & Prevention, 1, 505-513.
4. Bauman, K. E., Bryan, E. S., Dent, C. W., & Koch, G. G. (1983). The influence of observing carbon monoxide level on cigarette smoking by public prenatal patients. American Journal of Public Health, 73, 1089-1091.
5. Berman, B. A., & Gritz, E. R. (1991). Women and smoking: Current trends and issues for the 1990s. Journal of Substance Abuse, 3, 221-238.
6. Biener, L., & Abrams, D. B. (1991). The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.
7. Bjornson, W., Rand, C., Connett, J. E., Lindgren, P., Nides, M., Pope, F., Buist, A. S., Hoppe-Ryan, C., & O'Hara, P. (1995). Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health, 85, 223-230.
8. Caporaso, N., Pickle, L. W., Bale, S., Ayesh, R., Hetzel, M., & Idle, J. (1989). The distribution of debrisoquine metabolic phenotypes and implications for the suggested association with lung cancer risk. Genetic Epidemiology, 6, 517-524.
9. Centers for Disease Control. (1996). Cigarette smoking among adults - United States, 1994. Morbidity and Mortality Weekly Report, 45, 588-590.
10. Croyle, R. T., & Lerman, C. (1995). Psychological impact of genetic testing. In R. T. Croyle (Ed.), Psychosocial effects of screening for disease prevention and detection (pp. 11-38). New York: Oxford University Press.
11. Curry, S. J. (1993). Self-help interventions for smoking cessation. Journal of Consulting and Clinical Psychology, 61, 790-803.
12. DiClemente, C. C., Prochaska, J. O., Fairhurst, S. K., Velicer, W. F., Velasquez, M. M., & Rossi, J. S. (1991). The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59, 295-304.
13. Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, J. R., & Smith, R. L. (1980). A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. Journal of Medical Genetics, 17, 102-105.
14. Faden, R. R., & Beauchamp, T. L. (1986). A history and theory of informed consent. New York: Oxford University Press.
15. Glassman, A. H., Stetner, F., Walsh, B. T., Raizman, P. S., Fleiss, J. L., Cooper, T. B., & Covey, L. S. (1988). Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial. Journal of the American Medical Association, 259, 2863-2866.
16. Gonzalez, F. J., & Meyer, U. A. (1991). Molecular genetics of the debrisoquin-sparteine polymorphism. Clinical Pharmacology Therapy, 50, 233-238.
17. Gritz, E. R., Berman, B. A., Bastani, R., & Wu, M. (1992). A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: Testing the limits of the public health model. Health Psychology, 11, 280-289.
18. 1 splice recognition site. American Journal of Human Genetics, 47, 994-1001.
19. Health Consultants Inc. (1993). Free & clear: A guide to quitting smoking on your own. Princeton, NJ: Health Enhancement Systems.
20. Hollis, J. F., Lichtenstein, E., Vogt, T. M., Stevens, V. J., & Biglan, A. (1993). Nurse-assisted counseling for smokers in primary care. Annals of Internal Medicine, 118, 521-525.
21. Imperial Cancer Research Fund General Practice Research Group. (1993). Effectiveness of a nicotine patch in helping people stop smoking: Results of a randomised trial in general practice. British Medical Journal, 306, 1304-1308.
22. Law, M. R., Hetzel, M. R., & Idel, J. R. (1989). Debrisoquine metabolism and genetic predisposition to lung cancer. British Journal of Cancer, 59, 686-687.
23. Lerman, C., Audrain, J., Orleans, C. T., Boyd, R., Gold, K., Main, D., & Caporaso, N. (1996). Investigation of mechanisms linking depressed mood to nicotine dependence. Addictive Behavior, 21, 9-19.
24. Lerman, C., & Croyle, R. (1994). Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine, 154, 609-616.
25. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., & Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision-making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
26. Lerman, C., Orleans, C. T., & Engstrom, P. F. (1993). Biological markers in smoking cessation treatment. Seminars in Oncology, 20, 359-367.
27. Leventhal, H., Safer, M. A., & Panagis, D. M. (1983). The impact of communications on the self-regulation of health beliefs, decisions, and behavior. Health Education Quarterly, 10, 3-29.
28. Leventhal, H., Watts, J. C., & Pagano, F. (1967). Effects of fear and instructions on how to cope with danger. Journal of Personality and Social Psychology, 6, 313-321.
29. Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
30. Nides, M. A., Rakos, R. F., Gonzales, D., Murray, R. P., Tashkin, D. P., Bjornson-Benson, W. M., Lindgren, P., & Connett, J. E. (1995). Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. Journal of Consulting and Clinical Psychology, 63, 60-69.
31. Orleans, C. T., Rotberg, H. L., Quade, D., & Lees, P. (1990). A hospital quit-smoking consult service: Clinical report and intervention guidelines. Preventive Medicine, 19, 198-212.
32. Orleans, C. T., Schoenbach, V. J., Wagner, E. H., Quade, D., Salmon, M. A., Pearson, D. C., Fiedler, J., Porter, C. Q., & Kaplan, B. H. (1991). Self-help quit smoking interventions: Effects of self-help materials, social support instructions, and telephone counseling. Journal of Consulting and Clinical Psychology, 59, 439-448.
33. Patrick, D. L., Cheadle, A., Thompson, D. C., Diehr, P., Koepsell, T., & Kinne, S. (1994). The validity of self-reported smoking: A review and meta-analysis. American Journal of Public Health, 84, 1086-1093.
34. Perera, F. P. (1996). Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention. Journal of the National Cancer Institute, 88, 496-509.
35. Pokorski, T. L., Chen, W. W., & Bertholf, R. L. (1994). Use of urine cotinine to validate smoking self-reports in U.S. Navy recruits. Addictive Behaviors, 19, 451-454.
36. Prochaska, J. O., Velicer, W. F., DiClemente, C. C., & Fava, J. (1988). Measuring processes of change: Applications to the cessation of smoking. Journal of Consulting and Clinical Psychology, 56, 520-528.
37. Prochaska, J. O., Velicer, W. F., Rossi, J. S., Goldstein, M. G., Marcus, B. H., Rakowski, W., Fiore, C., Harlow, L. L., Redding, C. A., Rosenbloom, D., & Rossi, S. R. (1994). Stages of change and decisional balance for 12 problem behaviors. Health Psychology, 13, 39-46.
38. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
39. Risser, N. L., & Belcher, D. W. (1990). Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: A randomized trial. Journal of General Internal Medicine, 5, 16-22.
40. Rothstein, M. A. (1990). Legal and ethical issues in the laboratory assessment of genetic susceptibility to cancer. Birth Defects - Original Article Series, 26, 179-190.
41. Russell, M. A., Stapleton, J. A., Feyerabend, C., Wiseman, S. M., Gustavsson, G., Sawe, U., & Connor, P. (1993). Targeting heavy smokers in general practice: Randomised controlled trial of transdermal nicotine patches. British Medical Journal, 306, 1308-1312.
42. Sutton, S., & Hallett, R. (1989). The contribution of fear and cognitive factors in mediating the effects of fear-arousing communications. Social Behaviour, 4, 83-98.
43. Velicer, W. F., DiClemente, C. C., Prochaska, J. O., & Brandenburg, N. (1985). Decisional balance measure for assessing and predicting smoking status. Journal of Personality and Social Psychology, 48, 1279-1289.
44. Velicer, W. F., Prochaska, J. O., Rossi, J. S., & Snow, M. G. (1992). Assessing outcome in smoking cessation studies. Psychological Bulletin, 111, 23-41.
45. Walker, W. B., & Franzini, L. R. (1985). Low-risk aversive group treatments, physiological feedback, and booster sessions for smoking cessation. Behavior Therapy, 16, 263-274.
46. Weinstein, N. D. (1982). Unrealistic optimism about susceptibility to health problems. Journal of Behavioral Medicine, 5, 441-461.
47. Weinstein, N. D., & Klein, W. M. (1995). Resistance of personal risk perceptions to debiasing interventions. Health Psychology, 14, 132-140.
48. Westman, E. C., Levin, E. D., & Rose, J. E. (1993). The nicotine patch in smoking cessation: A randomized trial with telephone counseling. Archives of Internal Medicine, 153, 1917-1923.
49. Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schlechter, M. T., & Hayden, M. R. (1992). The psychological consequences of predictive testing for Huntington's disease. New England Journal of Medicine, 327, 1401-1405.
50. Wilfond, B. S., & Fost, N. (1990). The cystic fibrosis gene: Medical and social implications for heterozygote detection. Journal of the American Medical Association, 263, 2777-2783.